期刊文献+

Risk factors for combined hepatocellular-cholangiocarcinoma:A hospital-based case-control study 被引量:11

Risk factors for combined hepatocellular-cholangiocarcinoma:A hospital-based case-control study
下载PDF
导出
摘要 AIM:To identify risk factors contributing to the development of combined hepatocellular-cholangiocarcinoma(CHC) in China.METHODS:One hundred and twenty-six patients with CHC and 4:1 matched healthy controls were interviewed during the period from February 2000 to October 2012.Logistic regression analysis was used to calculate odds ratios(OR)and 95%confidence intervals(CI)for each risk factor.RESULTS:Univariate analysis showed that the significant risk factors for CHC development were hepatitis B virus(HBV)infection,heavy alcohol consumption,a family history of liver cancer,and diabetes mellitus.Multivariate stepwise logistic regression analysis showed that HBV infection(OR=19.245,95%CI:13.260-27.931)and heavy alcohol consumption(OR=2.186,95%CI:1.070-4.466)were independent factors contributing to the development of CHC.CONCLUSION:HBV infection and heavy alcohol consumption may play a role in the development of CHC in China. AIM: To identify risk factors contributing to the development of combined hepatocellular-cholangiocarcinoma (CHC) in China.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第35期12615-12620,共6页 世界胃肠病学杂志(英文版)
关键词 Risk factors COMBINED hepatocellular-chol-angiocar Risk factors Combined hepatocellular-cholangiocarcinoma Hepatitis B virus Alcohol consumption Epidemiology
  • 相关文献

参考文献13

  • 1Xian-Huan Yu,Lei-Bo Xu,Hong Zeng,Rui Zhang,Jie Wang and Chao LiuAuthor Affiliations:Department of Hepato-Pancreato-Biliary Surgery and Department of Pathology,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,China.Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(6):620-625. 被引量:7
  • 2Gao, Chun,Yao, Shu-Kun.Diabetes mellitus: a “true” independent risk factor for hepatocellular carcinoma?[J].Hepatobiliary & Pancreatic Diseases International,2009,8(5):465-473. 被引量:23
  • 3Zuo, Huai-Quan,Yan, Lu-Nan,Zeng, Yong,Yang, Jia-Ying,Luo, Hong-Zhi,Liu, Jiang-Wen,Zhou, Li-Xin.Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2007,6(2):161-165. 被引量:12
  • 4Zongtang Sun,Taoyang Chen,Snorri S. Thorgeirsson,Qimin Zhan,Jianguo Chen,Ju-Hyun Park,Peixin Lu,Chu Chieh Hsia,Nengjin Wang,Libin Xu,Lingling Lu,Fei Huang,Yuanrong Zhu,Jianhua Lu,Zhengping Ni,Qinan Zhang,Yuying Wu,Guoting Liu,Zhiyuan Wu,Chunfeng Qu,Mitchell H. Gail.Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China[J].Carcinogenesis.2013(8)
  • 5Jun Akiba,Osamu Nakashima,Satoshi Hattori,Ken Tanikawa,Miki Takenaka,Masamich Nakayama,Reiichiro Kondo,Yoriko Nomura,Keiko Koura,Kousuke Ueda,Sakiko Sanada,Yoshiki Naito,Rin Yamaguchi,Hirohisa Yano.Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification[J].The American Journal of Surgical Pathology.2013(4)
  • 6Chern‐Horng Lee,Sen‐Yung Hsieh,Chee‐Jen Chang,Yu‐Jr Lin.Comparison of clinical characteristics of combined hepatocellular‐cholangiocarcinoma and other primary liver cancers[J].J Gastroenterol Hepatol.2012(1)
  • 7Jiayi Huang,Lihong Shen,Yongliang Lu,Hongli Li,Xifeng Zhang,Daixi Hu,Tao Feng,Fangzhou Song.Parallel induction of cell proliferation and inhibition of cell differentiationin hepatic progenitor cells by hepatitis B virus X gene[J].International Journal of Molecular Medicine.2012(4)
  • 8Xin Yin,Bo-Heng Zhang,Shuang-Jian Qiu,Zheng-Gang Ren,Jian Zhou,Xiao-Hong Chen,Ying Zhou,Jia Fan.Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis[J].Annals of Surgical Oncology.2012(9)
  • 9William C. Palmer,Tushar Patel.Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma[J].Journal of Hepatology.2012(1)
  • 10Mika Kurokawa,Naoki Hiramatsu,Tsugiko Oze,Takayuki Yakushijin,Masanori Miyazaki,Atsushi Hosui,Takuya Miyagi,Yuichi Yoshida,Hisashi Ishida,Tomohide Tatsumi,Shinichi Kiso,Tatsuya Kanto,Akinori Kasahara,Sadaharu Iio,Yoshinori Doi,Akira Yamada,Masahide Oshita,Akira Kaneko,Kiyoshi Mochizuki,Hideki Hagiwara,Eiji Mita,Toshifumi Ito,Yoshiaki Inui,Kazuhiro Katayama,Harumasa Yoshihara,Yasuharu Imai,Eijirou Hayashi,Norio Hayashi,Tetsuo Takehara.Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection[J].Journal of Gastroenterology.2012(5)

二级参考文献66

  • 1Yi-Mi He, Xiao-Yan Wang, Shang-Da Gao, Li-Yun Yu, Xiao-Dong Lin and Li-Wu Lin Fuzhou, China Department of Ultrasonography, Union Hospital of Fujian Medical University, Fujian Provincial Ultrasonic Medical Institute, Fuzhou 350001, China.Ultrasound-guided fine needle biopsy of intra- hepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):50-54. 被引量:12
  • 2Nussbaum T,Samarin J,Ehemann V,Bissinger M,Ryschich E,Khamidjanov A,et al.Autocrine insulin- like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesisHepatology,2008.
  • 3Allen RA;Lisa JR.Combined liver cell and bile duct carcinoma,1949.
  • 4Edge SB,,Byrd DR,Compton CC, et al.AJCC cancer staging manual. . 2010
  • 5El-Serag HB,Hampel H,Javadi F.The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clinics in Gastroenterology . 2006
  • 6Davila JA,Morgan RO,Shaib Y,McGlynn KA,El-Serag HB.Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study. Gut . 2005
  • 7Hassan MM,Hwang LY,Hatten CJ,et al.Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology . 2002
  • 8Dixon JB,Bhathal PS,O’Brien PE.Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology . 2001
  • 9Lawson,D.H.,Gray,J.M.,McKillop,C.Diabetes mellitus and primary hepatocellular carcinoma. Quarterly Journal of Medicine . 1986
  • 10Li D,Yeung SC,Hassan MM,Konopleva M,Abbruzzese JL.Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology . 2009

共引文献46

同被引文献87

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部